Table 1.
Variable | Group A N = 58 |
Group B N = 54 |
p value |
---|---|---|---|
Age (years), mean ± SD | 61 ± 4.1 | 59 ± 5.7 | p > 0.05 |
Body mass index, mean ± SD | 26.1 ± 3.0 | 26.4 ± 3.4 | p > 0.05 |
T-PSA lever (ng/ml), mean ± SD | 13.8 ± 2.7 | 14.4 ± 3.2 | p > 0.05 |
The operation method, n | |||
Open RP | 11 | 9 | |
Laparoscopic RP | 47 | 45 | p > 0.05 |
Biopsy Gleason score, mean ± SD | 6.8 ± 1.2 | 6.5 ± 1.3 | p > 0.05 |
Clinical tumor stage, n | |||
T1c | 22 | 24 | p > 0.05 |
T2 | 31 | 26 | |
T3 | 5 | 4 | |
Pathological stage, n | |||
pT2a | 8 | 5 | p > 0.05 |
pT2b | 15 | 16 | |
pT2c | 30 | 29 | |
pT3a | 4 | 3 | |
pT3b | 1 | 1 | |
Surgical margin apex, n | |||
Negative apex | 49 | 48 | p > 0.05 |
Positive apex | 9 | 6 | |
Prostate volume (ml), mean ± SD | 37.2 ± 4.9 | 45.6 ± 5.8 | p > 0.05 |